课题基金 / 基金详情

The NF2 gene: elucidation of tumor suppressor function

The NF2 gene: elucidation of tumor suppressor function
NF2基因:阐明肿瘤抑制功能
批准号:
6648978
负责人:
JOSEPH KISSIL
金额:
$4.81万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2005-04-30

项目摘要

项目成果

JOSEPH KISSIL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Neurofibromatosis type 2 (NF2) is an inherited disorder characterized by development of Schwann cell tumors of the eighth cranial nerve. The NF2 gene codes for a protein highly related to the ERM proteins moesin, ezrin and radixin and was thus termed merlin. The ERM proteins are thought to function as cell membrane-cytoskeleton linkers. Merlin is regulated, at least in part, by Rac/cdc42-dependent phosphorylation. Recent data implicates merlin as a possible negative regulator of the Rac/cdc42 signaling pathway. The proposed project focuses on the study of the tumor suppressive properties of merlin and the signaling pathways connecting extracellular signals to cytoskeletal organization and/or the proliferative state of the cell, via merlin. The work involves two combined approaches: 1) Understanding how merlin might interact with and regulate, the Rac/cdc42 signaling pathway. 2) Structure/function studies of merlin involving introduction of isoforms and mutated forms of the protein into Nf2-deficient cells. Specifically, mutations effecting merlin phosphorylation will be examined. The proposed project should shed light on the growth suppressive effects of merlin and possible cross-talk with the Rac/cdc42 pathway. This should lead to a better understanding of merlin function in normal cells and the consequences of its loss in tumor development. Such information will directly assist in the search for effective therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
Employing functionalized fragment libraries to identify therapeutic agents for neurofibromatosis type 2
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
海外基金